1.Botulinum Toxin A Treatment for Chronic Pain in Cerebral Palsy Patients
Makoto RYU ; Hideaki KUBOTA ; Yutaka OKETANI ; Yumi ITO ; Hiromichi HARA
The Japanese Journal of Rehabilitation Medicine 2007;44(7):398-401
Botulinum toxin A (BTX-A) was used in adult cerebral palsy patients for chronic pain treatment. Five patients (quadriplegia 3, diplegia 1, and athetosis 1 with an average age of 47) were all classified as GMFCS level IV. As a treatment for neck and trunk muscle pain, BTX-A injections were administered with a total dose below 6 units per kilogram of body weight. To investigate the efficacy of BTX-A, the Visual Analogue Scale and Modified Tsui Scale were used to evaluate the patients before and at regular monthly follow-ups after their injections. We found significant improvement in the Visual Analogue Scale scores at 1 month after initial injection and also found the same difference at the second injection. Also, although we found improvement in the Modified Tsui Scale scores at 1 month after injection, these improvements did not last as long as the Visual Analogue Scale improvements. BTX-A has been used in a growing number of indications for the treatment of muscle spasticity including blepharospasm, facial spasm and spasmodic torticollis. We found that BTX-A may also be useful in treating patients with cerebral palsy suffering from chronic pain.
2.Rehabilitation Improves Both the Prognosis and Activities of Daily Living Scores in Hemodialysis Patients
Hideki TSUKAHARA ; Yuya NAKAMURA ; Takuya MURAKAMI ; Misako ENDO ; Yoshinobu WATANABE ; Yu SHIMANO ; Masaki HARA ; Masatomo MIHARA ; Tatsuo SHIMIZU ; Michiyasu INOUE ; Yoshiyuki MATSUOKA ; Tsutomu ASANO ; Hiromichi GOTOH ; Yoshikazu GOTO
The Japanese Journal of Rehabilitation Medicine 2014;51(11):716-723
Background : The effects of rehabilitation on hemodialysis patients are unknown. We assessed the effects and investigated the association between rehabilitation treatment effects and all-cause mortality. Methods : This prospective cohort study included 120 patients on maintenance hemodialysis. ADL was assessed using the Functional Independence Measure (FIM) score (total points, 126), which comprises 13 motor items (total points, 91) and five cognitive items (total points, 35). A survival curve was constructed using the Kaplan-Meier analysis and stratified into an increase or no-increase of the FIM score. Multivariable logistic regression analysis was used to determine factors associated with the effects of rehabilitation. Discriminative sensitivity of FIM cognitive items for an increase in total FIM was estimated using the area under the receiver operating characteristic (AuROC) curve. Results : The average total FIM score increased from 64.2±3.6 to 75.8±3.0, and the increase in FIM motor and cognitive items was 11.0±1.3 and 0.5±0.6, respectively. The cumulative survival rate within 2.5 years was significantly higher in the FIM increase group than that in the FIM no-increase group. FIM cognitive items and anemia were significantly associated with rehabilitation effects, and AuROC showed that a cutoff of 34 points in cognitive FIM had moderate discriminative sensitivity for a total FIM increase (AuC, 0.719 ; p<0.0008). Conclusions : Rehabilitating hemodialysis patients improved their FIM score (particularly the motor items), and a higher FIM score resulted in a better prognosis. The effectiveness of rehabilitation depends on maintaining a perfect FIM cognitive score.
3.Infectious peritonitis after endoscopic ultrasound-guided biliary drainage in a patient with ascites
Nozomi OKUNO ; Kazuo HARA ; Nobumasa MIZUNO ; Takamichi KUWAHARA ; Hiromichi IWAYA ; Masahiro TAJIKA ; Tsutomu TANAKA ; Makoto ISHIHARA ; Yutaka HIRAYAMA ; Sachiyo ONISHI ; Kazuhiro TORIYAMA ; Ayako ITO ; Naosuke KURAOKA ; Shimpei MATSUMOTO ; Masahiro OBATA ; Muneji YASUDA ; Yusuke KURITA ; Hiroki TANAKA ; Yasumasa NIWA
Gastrointestinal Intervention 2018;7(1):40-43
SUMMARY OF EVENT: Bacterial, mycotic peritonitis and Candida fungemia developed in a patient with moderate ascites who had undergone endoscopic ultrasound-guided biliary drainage (EUS-BD). Antibiotics and antifungal agent were administered and ascites drainage was performed. Although the infection improved, the patient's general condition gradually deteriorated due to aggravation of the primary cancer and he died. TEACHING POINT: This is the first report to describe infectious peritonitis after EUS-BD. Ascites carries the potential risk of severe complications. As such, in patients with ascites, endoscopic retrograde cholangiopancreatography (ERCP) is typically preferred over EUS-BD or percutaneous drainage to prevent bile leakage. However, ERCP may not be possible in some patients with tumor invasion of the duodenum or with surgically altered anatomy. Thus, in patients with ascites who require EUS-BD, we recommend inserting the drainage tube percutaneously and draining the ascites before and after the intervention in order to prevent severe infection.
Anti-Bacterial Agents
;
Ascites
;
Bile
;
Candida
;
Cholangiopancreatography, Endoscopic Retrograde
;
Drainage
;
Duodenum
;
Endosonography
;
Fungemia
;
Humans
;
Peritonitis